RASGRP1 and hepatocellular carcinoma: Several studies have also demonstrated that RASGRP1 regulated cell proliferation and could be a novel therapeutic target via influencing other pathways in leukemia 52, hepatocellular carcinoma (HCC) 53 and CRC 54.